Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asker Healthcare Group ABOSTO:ASKER -7.71%13 Return-on-Tangible-Asset is 11.17% as of Jun. 2026, which is 62% above its 10-year median of 6.91. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Asker Healthcare Group AB ranks better than 86.44% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Asker Healthcare Group AB's annualizedNet Income for the quarter that ended in Jun. 2026 was kr876 Mil. Asker Healthcare Group AB's average total tangible assets for the quarter that ended in Jun. 2026 was kr7,844 Mil. Therefore, Asker Healthcare Group AB's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 11.17%.
The historical rank and industry rank for Asker Healthcare Group AB's Return-on-Tangible-Asset or its related term are showing as below:
OSTO:ASKER'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 4.33 Med: 6.91 Max: 9.91
Current: 9.17
During the past 4 years, Asker Healthcare Group AB's highest Return-on-Tangible-Asset was 9.91%. The lowest was 4.33%. And the median was 6.91%.
OSTO:ASKER's Return-on-Tangible-Asset is ranked better than 86.44% of 118
companies
in the Medical Distribution industry
Industry Median: 2.34
vs OSTO:ASKER: 9.17
Asker Healthcare Group AB (OSTO:ASKER) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Asker Healthcare Group AB Return-on-Tangible-Asset Related Terms
Asker Healthcare Group AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Asker Healthcare Group AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB Return-on-Tangible-Asset Chart
OSTO:ASKER vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Asker Healthcare Group AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 11.17% mean?
Asker Healthcare Group AB (OSTO:ASKER) has a Return-on-Tangible-Asset of 11.17% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Asker Healthcare Group AB and its competitors. This is 62% above median its historical median of 6.91. Over the past decade, Asker Healthcare Group AB's Return-on-Tangible-Asset has ranged from 4.33 to 9.91. According to the industry distribution chart, Asker Healthcare Group AB ranks #16 out of 118 companies in the Medical Distribution industry, placing it in the top 13.6%.
Is Asker Healthcare Group AB's Return-on-Tangible-Asset too high?
Asker Healthcare Group AB's current Return-on-Tangible-Asset of 11.17% is 62% above median its 10-year median of 6.91. Over the past 10 years, this metric has ranged from a low of 4.33 to a high of 9.91. The Medical Distribution industry median Return-on-Tangible-Asset is 2.34. Asker Healthcare Group AB's value of 11.17% is 377.4% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #16 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #16 out of 118 companies for Return-on-Tangible-Asset. This places Asker Healthcare Group AB in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.34. Asker Healthcare Group AB's value of 11.17% is 377.4% above this benchmark. Historically, Asker Healthcare Group AB's own Return-on-Tangible-Asset has ranged from 4.33 to 9.91 over the past decade. While the company's 10-year median is 6.91 vs. the industry median of 2.34, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.34, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current Return-on-Tangible-Asset of 11.17% is 377.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current Return-on-Tangible-Asset is 11.17%, which is 62% above median its own 10-year median of 6.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Return-on-Tangible-Asset of 11.17%. The current Return-on-Tangible-Asset is 11.17%, which is 62% above median its 10-year median of 6.91 and 377.4% above the Medical Distribution industry median of 2.34. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Return-on-Tangible-Asset is 11.17% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
